Securities Registration: Employee Benefit Plan (s-8)
August 10 2021 - 5:01PM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on August 10, 2021
|
Registration
No. 333-______
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
S-8
REGISTRATION
STATEMENT UNDER
THE SECURITIES ACT OF 1933
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
27-1865814
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(I.R.S.
Employer
Identification No.)
|
3900
Paseo del Sol
Santa
Fe, NM 87507
(505)
438-2576
(Address
of Principal Executive Offices) (Zip Code)
2013
EQUITY INCENTIVE PLAN, AS AMENDED, OF SIGMA LABS, INC.
(Full
title of the plan)
Mark
K. Ruport, President and Chief Executive Officer
Sigma
Labs, Inc.
3900
Paseo del Sol
Santa
Fe, NM 87507
(Name
and address of agent for service)
(505)
438-2576
(Telephone number, including area code, of agent for service)
Copy
to:
Darren Freedman
TroyGould PC
1801 Century Park East, Suite 1600
Los Angeles, California 90067
(310) 553-4441
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
[ ]
Large accelerated filer
|
|
[ ]
Accelerated filer
|
|
[X]
Non-accelerated filer
|
|
[X]
Smaller reporting company
|
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [ ]
CALCULATION
OF REGISTRATION FEE
Title of securities to be registered
|
|
Amount to be registered (1) (2)
|
|
Proposed
maximum
offering price
per share(3)
|
|
|
Proposed
maximum
aggregate
offering price(3)
|
|
|
Amount of
registration
fee(3)
|
|
Common Stock, $0.001 par value per share
|
|
875,000 shares
|
|
$
|
3.37
|
|
|
$
|
2,948,750
|
|
|
$
|
321.71
|
|
|
(1)
|
Pursuant
to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement covers,
in addition to the shares of common stock specified above, an indeterminate number of additional shares of common stock that may
become issuable under the 2013 Equity Incentive Plan, as amended (the “Plan”), as a result of the anti-dilution adjustment
provisions contained therein regarding stock splits, stock dividends and similar transactions.
|
|
|
|
|
(2)
|
As
described below in the Explanatory Note, this Registration Statement covers an additional 875,000 shares of Common Stock that are
reserved for future issuance under the Plan, and with respect to which the offering price is not currently known, as a result of
a recent amendment to the Plan increasing the number of shares of Common Stock that are issuable under the Plan.
|
|
|
|
|
(3)
|
The
proposed maximum offering price per share and maximum aggregate offering price for these shares were estimated, solely for purposes
of calculating the amount of the registration fee, in accordance with Rules 457(c) and 457(h) of the Securities Act based upon a
price of $3.37, which is the average of the high and low prices of the registrant’s common stock, as reported on The NASDAQ
Capital Market on August 4, 2021.
|
EXPLANATORY
NOTE
This
Registration Statement is filed pursuant to General Instruction E to Form S-8 by Sigma Labs, Inc., a Nevada corporation (the “Company”),
to register 875,000 shares of common stock of the Company in addition to those previously registered on the Company’s Registration
Statements on Form S-8 (File Nos. 333-197616, 333-212612, 333-222369, 333-228628, 333-233348, and 333-250181) filed with the Securities
and Exchange Commission on July 24, 2014, July 21, 2016, December 29, 2017, November 30, 2018 August 16, 2019, and November 18, 2020,
respectively, for issuance pursuant to the Company’s 2013 Equity Incentive Plan. Pursuant to General Instruction E to Form S-8,
this Registration Statement incorporates by reference the contents of such previously filed Registration Statements, except that the
provisions contained in Part II of such earlier Registration Statements are modified as set forth in this Registration Statement.
PART
II
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
ITEM
3.
|
Incorporation
of Documents by Reference
|
We
hereby incorporate by reference the following documents previously filed with the SEC:
|
●
|
Our
Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the SEC on March 24, 2021;
|
|
|
|
|
●
|
Our
Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 filed with the SEC on April 22, 2021 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 filed with the SEC on July 22, 2021;
|
|
|
|
|
●
|
Our
Current Reports on Form 8-K filed with the SEC on January 12, 2021, March 30, 2021, May 25, 2021, June 15, 2021 and July 16, 2021,
respectively;
|
|
|
|
|
●
|
Our
Definitive Proxy Statement on Schedule 14A filed with the SEC on June 15, 2021; and
|
|
|
|
|
●
|
The
description of our Common Stock contained in our Registration Statement on Form 8-A (File No. 001-38015) filed with the SEC on February
14, 2017, including any amendment or reports filed for the purpose of updating such description.
|
All
documents filed by Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration
Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered
hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference
herein and to be a part hereof from the date of filing of such documents. Any statement contained in this Registration Statement, in
an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or
superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed amendment
to this Registration Statement or in any document that is or is deemed to be incorporated by reference herein modifies or supersedes
such statement.
Under
no circumstances shall any information furnished prior to or subsequent to the date hereof under Item 2.02 or 7.01 of Form 8-K be deemed
incorporated herein by reference unless such Form 8-K expressly provides to the contrary.
Item
4.
|
Description of Securities.
|
Not
applicable.
The
following exhibits are filed with this registration statement or are incorporated by reference as a part of this Registration Statement:
Exhibit
No.
|
|
Exhibit
Description
|
|
|
|
4.1
|
|
Amended and Restated Articles of Incorporation of the Company, as amended (previously filed by the Company as Exhibit 3.1 to the Company’s Form 10-K, filed on March 24, 2021, and incorporated herein by reference).
|
|
|
|
4.2
|
|
Certificate of Change Pursuant to NRS 78.209 (previously filed by the Company as Exhibit 3.1 to the Company’s Form 8-K, filed on February 28, 2020, and incorporated herein by reference).
|
|
|
|
4.3
|
|
Amended and Restated Bylaws of the Company, as amended (filed as Exhibit 3.12 to the Company’s Form 10-K, filed on March 24, 2021, and incorporated herein by reference).
|
|
|
|
5.1
|
|
Opinion of TroyGould PC with respect to the securities being registered (included with this registration statement).
|
|
|
|
23.1
|
|
Consent of Haynie & Company (included with this registration statement).
|
|
|
|
23.2
|
|
Consent of TroyGould PC (included in the opinion filed as Exhibit 5.1).
|
|
|
|
24.1
|
|
Power of Attorney (contained on the signature page of this Registration Statement).
|
|
|
|
99.1
|
|
Sigma Labs, Inc. 2013 Equity Incentive Plan (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed July 16, 2021, and incorporated herein by reference).
|
|
|
|
99.2
|
|
Form of Nonqualified Stock Option Agreement for the Plan (previously filed by the Company as Exhibit 10.4 to the Company’s Form 10-K, filed on April 1, 2019, and incorporated herein by reference).
|
|
|
|
99.3
|
|
Form of Incentive Stock Option Agreement for the Plan (previously filed by the Company as Exhibit 4.3 to the Company’s Form S-8 Registration Statement, filed on July 24, 2014, and incorporated herein by reference).
|
|
|
|
99.4
|
|
Form of Restricted Stock Agreement for the Plan (previously filed by the Company as Exhibit 10.6 to the Company’s Form 10-K, filed on April 1, 2019, and incorporated herein by reference).
|
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Santa Fe, State of New Mexico, on August 10, 2021.
|
SIGMA
LABS, INC.
|
|
|
|
By:
|
/s/
Mark K. Ruport
|
|
|
Mark
K. Ruport
|
|
|
President
and Chief Executive Officer
|
POWER
OF ATTORNEY
Each
person whose signature appears below constitutes and appoints Mark K. Ruport as his true and lawful attorney-in-fact and agent, with
full power of substitution, for him in any and all capacities, to sign this registration statement on Form S-8 and any amendments hereto
(including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, and
other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full
power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as he
might do or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes,
may do or cause to be done by virtue of this power of attorney.
Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
indicated and on August 10, 2021.
Signature
|
|
Title
|
|
|
|
/s/
Mark K. Ruport
|
|
President,
Chief Executive Officer (principal executive officer) and Director
|
Mark
K. Ruport
|
|
|
|
|
|
/s/
JOHN RICE
|
|
Chairman
of the Board
|
John
Rice
|
|
|
|
|
|
/s/
FRANK Orzechowski
|
|
Chief
Financial Officer, Treasurer and Secretary (principal financial and accounting officer)
|
Frank
Orzechowski
|
|
|
|
|
|
/s/
SALVATORE BATTINELLI
|
|
Director
|
Salvatore
Battinelli
|
|
|
|
|
|
/s/
DENNIS DUITCH
|
|
Director
|
Dennis
Duitch
|
|
|
|
|
|
/s/
KENT SUMMERS
|
|
Director
|
Kent
Summers
|
|
|
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2023 to Apr 2024